CA 125 measured before second-look laparotomy is an independent prognostic factor for survival in patients with epithelial ovarian cancer
- 1 June 1992
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 45 (3) , 323-328
- https://doi.org/10.1016/0090-8258(92)90313-8
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Correlation of abdominal ultrasound and computed tomography scans with second- or third-look laparotomy in patients with ovarian carcinomaGynecologic Oncology, 1990
- Survival of patients with ovarian epithelial carcinomas after second-look laparotomyGynecologic Oncology, 1990
- Measurement of the ovarian cancer-associated antigen CA 125 prior to second look operationEuropean Journal of Cancer and Clinical Oncology, 1988
- The clinical value of serum CA125 levels in ovarian cancer patients receiving platinum therapyEuropean Journal of Cancer and Clinical Oncology, 1987
- Predictive value of serial CA 125 antigen levels in ovarian cancer evaluated by second-look laparotomyEuropean Journal of Cancer and Clinical Oncology, 1987
- CA-125 in gynecological malignanciesEuropean Journal of Cancer and Clinical Oncology, 1987
- CA125 Serum Levels and Secondary Laparotomy in Epithelial Ovarian TumoursAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1987
- CA 125 Serum Levels Correlated With Second-Look Operations Among Ovarian Cancer PatientsObstetrics & Gynecology, 1986
- Computed tomography in evaluation of patients with ovarian carcinoma in complete clinical remission. Correlation with surgical-pathologic findingsJAMA, 1986
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983